Householder Group Estate & Retirement Specialist LLC trimmed its position in shares of Healthcare Realty Trust Incorporated (NYSE:HR – Free Report) by 74.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,779 shares of the real estate investment trust’s stock after selling 5,153 shares during the quarter. Householder Group Estate & Retirement Specialist LLC’s holdings in Healthcare Realty Trust were worth $30,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of HR. Pzena Investment Management LLC purchased a new position in shares of Healthcare Realty Trust during the 3rd quarter valued at about $40,392,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Healthcare Realty Trust by 358.2% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,142,110 shares of the real estate investment trust’s stock worth $38,879,000 after purchasing an additional 1,674,583 shares during the period. Renaissance Technologies LLC purchased a new position in Healthcare Realty Trust in the 2nd quarter worth approximately $10,304,000. Millennium Management LLC increased its stake in Healthcare Realty Trust by 1,003.2% in the 2nd quarter. Millennium Management LLC now owns 435,977 shares of the real estate investment trust’s stock worth $7,185,000 after purchasing an additional 396,456 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Healthcare Realty Trust by 7.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,856,286 shares of the real estate investment trust’s stock worth $96,513,000 after purchasing an additional 395,243 shares during the period.
Healthcare Realty Trust Stock Performance
Shares of HR stock opened at $16.49 on Friday. Healthcare Realty Trust Incorporated has a fifty-two week low of $12.77 and a fifty-two week high of $18.90. The firm has a market cap of $5.85 billion, a P/E ratio of -10.44 and a beta of 0.94. The business’s 50 day moving average price is $17.26 and its 200-day moving average price is $17.56.
Healthcare Realty Trust Dividend Announcement
Insider Activity at Healthcare Realty Trust
In other news, Director Thomas N. Bohjalian purchased 7,750 shares of the company’s stock in a transaction that occurred on Friday, November 22nd. The shares were bought at an average cost of $17.39 per share, for a total transaction of $134,772.50. Following the completion of the transaction, the director now directly owns 50,002 shares of the company’s stock, valued at $869,534.78. This trade represents a 18.34 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Robert E. Hull sold 10,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $17.48, for a total value of $174,800.00. Following the sale, the chief operating officer now owns 171,400 shares in the company, valued at $2,996,072. This represents a 5.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have bought 18,750 shares of company stock worth $323,723 over the last ninety days. 0.56% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the company. Wells Fargo & Company reaffirmed an “underweight” rating and issued a $17.00 price target (up from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st. Wedbush cut Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $18.00 to $16.00 in a research note on Thursday, January 2nd. Jefferies Financial Group cut Healthcare Realty Trust from a “buy” rating to a “hold” rating and decreased their price target for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Finally, JPMorgan Chase & Co. lowered Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research report on Friday, December 20th. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $17.14.
View Our Latest Analysis on HR
Healthcare Realty Trust Profile
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
Further Reading
- Five stocks we like better than Healthcare Realty Trust
- The Role Economic Reports Play in a Successful Investment Strategy
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding HR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Realty Trust Incorporated (NYSE:HR – Free Report).
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.